Human Genome Epidemiology Literature Finder
|
Records 1 - 17 (of 17 Records) |
| Query Trace: Gallbladder Neoplasms and KRAS[original query] |
|---|
| A novel polymorphism in codon 25 of the KRAS gene associated with gallbladder carcinoma patients of the eastern part of India. Genetic testing and molecular biomarkers 2011 Jun 15 (6): 431-4. Pramanik Vishmadeb, Sarkar Biswanath N, Kar Madhuchanda, Das Gautam, Malay Barman K, Sufia Khannam K, Lakkakula Bhaskar V K S, Vadlamudi Rao |
| Mutation profiling in gallbladder cancer in Indian population. Indian journal of pathology & microbiology 0 57 (1): 9-12. Kumari Niraj, Corless Christopher L, Warrick Andrea, Beadling Carol, Nelson Dylan, Neff Tanay, Krishnani Narendra, Kapoor Vinay Kum |
| A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population. Journal of cancer research and clinical oncology 2016 Sep . Kazmi Hasan Raza, Chandra Abhijit, Kumar Saket, Satyam Leena Khare, Gupta Annapurna, Nigam Jaya, Srivastava Meenu, Mittal Balr |
| Mutation analysis and copy number changes of KRAS and BRAF genes in Taiwanese cases of biliary tract cholangiocarcinoma. Journal of the Formosan Medical Association = Taiwan yi zhi 2016 Oct . Huang Wen-Chih, Tsai Chien-Chen, Chan Chih-Chi |
| Mutational frequency of KRAS, NRAS, IDH2, PIK3CA, and EGFR in North Indian gallbladder cancer patients. Ecancermedicalscience 2017 11 757. Sharma Aarti, Kumar Ashok, Kumari Niraj, Krishnani Narendra, Rastogi Neer |
| Kras upregulates Notch signaling to induce gallbladder tumorigenesis in mice. Oncoscience 2017 Sep 4 (9-10): 131-138. Chung Wen-Cheng, Wang Junqing, Zhou Yunyun, Xu Ke |
| ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer. International journal of cancer 2018 Oct . Iyer Prajish, Shrikhande Shailesh V, Ranjan Malika, Joshi Asim, Gardi Nilesh, Prasad Ratnam, Dharavath Bhasker, Thorat Rahul, Salunkhe Sameer, Sahoo Bikram, Chandrani Pratik, Kore Hitesh, Mohanty Bhabani, Chaudhari Vikram, Choughule Anuradha, Kawle Dhananjay, Chaudhari Pradip, Ingle Arvind, Banavali Shripad, Gera Poonam, Ramadwar Mukta R, Prabhash Kumar, Barreto Savio George, Dutt Shilpee, Dutt Am |
| Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker. European journal of cancer (Oxford, England : 1990) 2019 Aug 120 31-39. Chae Heejung, Kim Deokhoon, Yoo Changhoon, Kim Kyu-Pyo, Jeong Jae Ho, Chang Heung-Moon, Lee Sang Soo, Park Do Hyun, Song Tae Jun, Hwang Shin, Kim Ki-Hun, Song Gi-Won, Ahn Chul Soo, Lee Jae Hoon, Hwang Dae Wook, Kim Song Cheol, Jang Se Jin, Hong Seung-Mo, Kim Tae Won, Ryoo Baek-Ye |
| Genetic Changes of P and Kras in Gallbladder Carcinoma in Kumaon Region of Uttarakhand. Journal of gastrointestinal cancer 2019 8 51 (2): 552-559. Shukla Sanjeev Kumar, Singh Govind, Shahi Kedar Singh, Bhuvan , Pant Prabh |
| Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification? HPB : the official journal of the International Hepato Pancreato Biliary Association 2019 May . Bagante Fabio, Ruzzenente Andrea, Conci Simone, Rusev Borislav C, Simbolo Michele, Campagnaro Tommaso, Pawlik Timothy M, Luchini Claudio, Iacono Calogero, Scarpa Aldo, Guglielmi Alfre |
| Genomic Characterization of ERBB2-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine. JCO precision oncology 2020 9 3 . Mondaca Sebastian, Razavi Pedram, Xu Chongrui, Offin Michael, Myers Mackenzie, Scaltriti Maurizio, Hechtman Jaclyn F, Bradley Mikaela, O'Reilly Eileen M, Berger Michael F, Solit David B, Li Bob T, Abou-Alfa Ghassan |
| Mutational spectrum and precision oncology for biliary tract carcinoma. Theranostics 2021 3 11 (10): 4585-4598. Lin Jianzhen, Cao Yinghao, Yang Xu, Li Guangyu, Shi Yang, Wang Dongxu, Long Junyu, Song Yang, Mao Jinzhu, Xie Fucun, Bai Yi, Zhang Lei, Yang Xiaobo, Wan Xueshuai, Wang Anqiang, Guan Mei, Zhao Lin, Hu Ke, Pan Jie, Huo Li, Lu Xin, Mao Yilei, Sang Xinting, Zhang Henghui, Wang Kai, Wang Xiaoyue, Zhao Hait |
| MAP kinase and mammalian target of rapamycin are main pathways of gallbladder carcinogenesis: results from bioinformatic analysis of next generation sequencing data from a hospital-based cohort (NCT05404347). Molecular biology reports 2022 8 49 (11): 10153-10163. Rajput Monika, Chigurupati Satyavjiay, Purwar Roli, Shukla Mridula, Pandey Man |
| Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures. JCO precision oncology 2022 6 6 e2100510. Mody Kabir, Jain Prerna, El-Refai Sherif M, Azad Nilofer S, Zabransky Daniel J, Baretti Marina, Shroff Rachna T, Kelley R Katie, El-Khouiery Anthony B, Hockenberry Adam J, Lau Denise, Lesinski Gregory B, Yarchoan Ma |
| Genomic profiling of gallbladder carcinoma: Targetable mutations and pathways involved. Pathology, research and practice 2022 3 232 153806. Mishra Sridhar, Kumari Swati, Srivastava Pallavi, Pandey Anshuman, Shukla Saumya, Husain Nuzh |
| Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis. Frontiers in oncology 2023 7 13 1086266. Xiangpeng Meng, Jia Ma, Nan Meng, Tianyu Yun, Beifang N |
| Genomics driven precision oncology in advanced biliary tract cancer improves survival. Neoplasia (New York, N.Y.) 2023 6 42 100910. Chandan Kumar-Sinha, Pankaj Vats, Nguyen Tran, Dan R Robinson, Valerie Gunchick, Yi-Mi Wu, Xuhong Cao, Yu Ning, Rui Wang, Erica Rabban, Janice Bell, Sunita Shankar, Rahul Mannan, Yuping Zhang, Mark M Zalupski, Arul M Chinnaiyan, Vaibhav Sah |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: